Article

VSP will cover Google Glass

 

San Francisco-VSP and Google have struck a deal to offer subsidized frames and prescription lenses for Google Glass, the Internet-connected eyewear.

“We know our 64 million members are seeing and hearing about Google Glass and how it will affect their lives and vision, so we are really focusing on the eye health management perspective,” said Jim McGrann, president of VSP Vision Care, VSP’s insurance division. “We see this whole concept of smart eyewear continuing to evolve as an opportunity to provide instant information.”

The hurdle to persuade people to wear a computer on their bodies is lower if the computer is attached to something they are already accustomed to wearing, like glasses or a watch.

Google’s design team, led by Isabelle Olsson, designed frames for Glass in four styles-made of lightweight titanium-partly because Glass’s processor and battery add weight.

“The key business model of the year for wearables is becoming embedded into the health care system,” said J.P. Gownder, an analyst studying wearable devices at Forrester Research, Cambridge, MA. “Selling wearable consumer electronics one-on-one to individual consumers is kind of a tough business.

“By embedding them into the health care system, you can reach a mass market,” he continued.

The Glass computing device, which costs $1,500 for people invited to buy the current version, will retail for several hundred dollars less than that later this year when Google introduces the consumer version. VSP will reimburse members based on their prescription lenses, but it will not subsidize the computer portion of Glass.

VSP and Google have also created a training program for optometrists to learn how to mount the Glass device on frames and fit Glass on people’s faces.

A VSP lab in Sacramento will cut the lenses for Glass frames as well.

 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.